Prognostic Biomarkers of Severe Disease in COVID-19 Patients
Jeffrey Henderson, M.D., Ph.D.
The aim of this project is to search for biomarkers that will identify COVID-19 patients who may be at high risk for progressing to severe disease. If successful, the results will improve morbidity, mortality, and utilization of healthcare resources by:
1) directing high-risk patients to closer medical monitoring;
2) identifying patients who benefit from early treatment; and 3) optimizing use of limited treatments.